October 18, 1994

A series of dihydrophenanthreneones and tetrahydrophenanthreneones are useful as inhibitors of 5.alpha.-reductase, and a series of hexahydrophenanthreneones are useful as intermediates for preparing such pharmaceuticals.

16

October 18, 1994

08/166,471

December 13, 1993

514/656   514/183 514/475 514/510 514/567 514/619 514/864 514/880 549/544 552/1 560/45 562/452 564/163 564/427

C07C   225/00   (20060101)   C07C   225/20   (20060101)   C07C   247/14   (20060101)   C07C   247/00   (20060101)   C07D   303/00   (20060101)   C07D   303/32   (20060101)  

514/183   514/475   514/656   514/864   514/880   549/544   552/1   564/427  

	5622961 - 5.alpha.-reductase inhibitors - Owned by Eli Lilly and Company (Indianapolis, IN) A series of benzoquinolin-3-ones are pharmaceuticals effective in treating conditions consequent on both Type I and Type II 5.alpha.-reductase.
	5622962 - 5.alpha.-reductase inhibitors - Owned by Eli Lilly and Company (Indianapolis, IN) A series of benzoquinolin-3-ones are pharmaceuticals effective in treating conditions consequent on both Type I and Type II 5.alpha.-reductase.
	5609858 - Method for treatment of androgenic alopecia A method of treatment for androgenic alopecia is disclosed wherein Liquor Carbonis Detergens is topically administered.